Rivoglitazone Hydrochloride

N/A

Report date: 2026/03/09 20:02:04
NME

Base Information

Drug NameRivoglitazone Hydrochloride
Drug Alias Name盐酸利格列酮rivoglitazonum利格列酮rivoglitazonarivoglitazone +[11
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor γ agonists
TargetsPeroxisome proliferator-activated receptor γ
Therapy Area/IndicationsDiabetes Mellitus, Type 2Dry Eye SyndromesXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesUkraine +[20
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Dry Eye SyndromesXerophthalmia

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG